Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

A new rating scale for Alzheimer's disease

(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · see citing works

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial

Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178 · see citing works

Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census

Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · see citing works

Memantine in Moderate-to-Severe Alzheimer's Disease

Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043 · see citing works

Psychiatric and Physical Morbidity Effects of Dementia Caregiving: Prevalence, Correlates, and Causes

Schulz, R., O'Brien, A. T., Bookwala, J., & Fleissner, K. (1995) · The Gerontologist · doi:10.1093/geront/35.6.771 · Cited by 1,765 · see citing works

Practice parameter: Management of dementia (an evidence-based review) [RETIRED]

Doody, R. S., Stevens, J. E., Beck, C., Dubinsky, R., Kaye, J. A., Gwyther, L. P., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,703 · see citing works

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618 · see citing works

Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410 · see citing works

Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil: A Randomized Controlled Trial

Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403 · see citing works

Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

Orgogozo, J.-M., Gilman, S., Dartigues, J.-F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000073623.84147.a8 · Cited by 1,356 · see citing works

An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease

Galasko, D., Bennett, D. A., Sano, M., Ernesto, C., Thomas, R., Grundman, M., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00005 · Cited by 1,198 · see citing works

The spectrum of behavioral changes in Alzheimer's disease

Mega, M., Cummings, J., Fiorello, T., & Gornbein, J. (1996) · Neurology · doi:10.1212/wnl.46.1.130 · Cited by 1,124 · see citing works

Dietary Intake of Antioxidants and Risk of Alzheimer Disease

Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080 · see citing works

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · see citing works

Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease

Mulnard, R. A., Cotman, C. W., Kawas, C. H., van Dyck, C. H., Sano, M. C., Doody, R. S., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 984 · see citing works

Meta‐Analysis of Psychosocial Interventions for Caregivers of People with Dementia

Brodaty, H., Green, A., & Koschera, A. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1600-0579.2003.00210.x · Cited by 952 · see citing works

Positron Emission Tomography in Evaluation of Dementia

Silverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J. G., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 939 · see citing works

Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data

Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 881 · see citing works

Untitled work

Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870 · see citing works

Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease

Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829 · see citing works

Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease

Höck, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Müller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00294-0 · Cited by 777 · see citing works

Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia

Katz, I. R., Jeste, D. V., Mintzer, J. E., Clyde, C., Napolitano, J. A., Brecher, M., & The Risperidone Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0207 · Cited by 741 · see citing works

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

Winblad, B. G., Engedal, K., Soininen, H. S., Verhey, F. R. J., Waldemar, G., Wimo, A. B., Wetterholm, A.-L., Zhang, R., Haglund, A., Subbiah, P., et al. (2001) · Neurology · doi:10.1212/wnl.57.3.489 · Cited by 721 · see citing works

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1

Allanbutterfield, D., Castegna, A., Lauderback, C. M., & Drake, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715 · see citing works

Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change

Schneider, L., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, ‌., Schmitt, F. A., Grundman, M., Thomas, R. G., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00004 · Cited by 647 · see citing works

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

Deyn, P. P. D., Rabheru, K., Rasmussen, A. M. L., Bocksberger, J. P., DAUTZENBERG, P. L. J., Eriksson, S., & LAWLOR, B. A. (1999) · Neurology · doi:10.1212/wnl.53.5.946 · Cited by 611 · see citing works

Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique

Cohen-Mansfield, J. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00005 · Cited by 593 · see citing works

The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease

Oken, B., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585 · see citing works

Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities

Street, J. S. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.968 · Cited by 583 · see citing works

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype

Craft, S., Peskind, E., Schwartz, M. W., Schellenberg, G. D., Raskind, M., & Porte, D. (1998) · Neurology · doi:10.1212/wnl.50.1.164 · Cited by 560 · see citing works

Estrogen for Alzheimer’s disease in women

Henderson, V. W., Paganini‐Hill, A., Miller, B. L., Elble, R. J., Reyes, P. F., Shoupe, D., McCleary, C. A., Klein, R., Hake, A. M., & Farlow, M. R. (2000) · Neurology · doi:10.1212/wnl.54.2.295 · Cited by 548 · see citing works

Documentation and Evaluation of Cognitive Impairment in Elderly Primary Care Patients

Callahan, C. M., Hendrie, H. C., & Tierney, W. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-6-199503150-00004 · Cited by 521 · see citing works

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia

Brodaty, H., Ames, D., Snowdon, J., Woodward, M., Kirwan, J., Clarnette, R., Lee, E., Lyons, B., & Grossman, F. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0205 · Cited by 464 · see citing works

A randomized controlled trial of prednisone in Alzheimer’s disease

Aisen, P. S., Davis, K. L., Berg, J. D., Schafer, K., Campbell, K., Thomas, R. G., Weiner, M. F., Farlow, M. R., Sano, M., Grundman, M., et al. (2000) · Neurology · doi:10.1212/wnl.54.3.588 · Cited by 464 · see citing works

Neuroplasticity Failure in Alzheimer's Disease

Mesulam, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81109-5 · Cited by 449 · see citing works

Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia

Tariot, P. N., Erb, R., Podgorski, C. A., Cox, C., Patel, S., Jakimovich, L., & Irvine, C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.54 · Cited by 422 · see citing works

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease

Scharf, S., Mander, A. G., Ugoni, A., Vajda, F. J. E., & Christophidis, N. (1999) · Neurology · doi:10.1212/wnl.53.1.197 · Cited by 385 · see citing works

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

Tariot, P. N., Cummings, J. L., Katz, I. R., Mintzer, J. E., Perdomo, C. A., Schwam, E. M., & Whalen, E. (2001) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2001.49266.x · Cited by 373 · see citing works

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

Doody, R. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.427 · Cited by 362 · see citing works

A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes

Esposito, E., Rotilio, D., DIMATTEO, V., Giulio, C. D., Cacchio, M., & Algeri, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00078-7 · Cited by 327 · see citing works

Explicit Memory in Alzheimer's, Huntington's, and Parkinson's Diseases

Pillon, B., Deweer, B., Agid, Y., & Dubois, B. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040036010 · Cited by 315 · see citing works

Analysis of the episodic memory deficit in early Alzheimer's disease: Evidence from the doors and people test

Greene, J. D. W., Baddeley, A. D., & Hodges, J. R. (1996) · Neuropsychologia · doi:10.1016/0028-3932(95)00151-4 · Cited by 277 · see citing works

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

Rogers, S. L., Doody, R. S., Pratt, R. D., & Ieni, J. R. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00067-5 · Cited by 265 · see citing works

Management of Verbally Disruptive Behaviors in Nursing Home Residents

Cohen‐Mansfield, J., & Werner, P. (1997) · The Journals of Gerontology Series A · doi:10.1093/gerona/52a.6.m369 · Cited by 238 · see citing works

A Randomized, Placebo-Controlled Dose-Comparison Trial of Haloperidol for Psychosis and Disruptive Behaviors in Alzheimer’s Disease

Devanand, D. P., Marder, K. S., Michaels, K. S., Sackeïm, H. A., Bell, K. L., Sullivan, M. A., Cooper, T. B., Pelton, G. H., & Mayeux, R. P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1512 · Cited by 236 · see citing works

Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sertraline in the Treatment of Depression Complicating Alzheimer’s Disease: Initial Results From the Depression in Alzheimer’s Disease Study

Lyketsos, C. G., Leoutsakos, J., Steele, C. D., Kopunek, S., Steinberg, M., Baker, A. S., Brandt, J., & Rabins, P. V. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1686 · Cited by 214 · see citing works

Placebo-Controlled Study of Divalproex Sodium for Agitation in Dementia

Porsteinsson, A. P., Tariot, P. N., Erb, R., Cox, C., Smith, E., Jakimovich, L. J., Noviasky, J. A., Kowalski, N., Holt, C. J., & Irvine, C. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200102000-00009 · Cited by 206 · see citing works

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

Small, G. W. (1997) · JAMA · doi:10.1001/jama.278.16.1363 · Cited by 203 · see citing works

Use of Cholinesterase Inhibitors in Clinical Practice: Evidence-Based Recommendations

Cummings, J. L. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200303000-00004 · Cited by 202 · see citing works

Possible neurotransmitter basis of behavioral changes in alzheimer's disease

Palmer, A. M., Stratmann, G. C., PROCTER, A. W., & Bowen, D. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230616 · Cited by 194 · see citing works

Therapeutic strategies for Alzheimer's disease

Wolfe, M. S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd938 · Cited by 189 · see citing works

A Double-Blind, Randomized, Fixed-Dose Trial of Fluoxetine vs. Amitriptyline in the Treatment of Major Depression Complicating Alzheimer's Disease

Taragano, F. E., Lyketsos, C. G., Mangone, C. A., Allegri, R., & Díaz, E. C. (1997) · Psychosomatics · doi:10.1016/s0033-3182(97)71461-0 · Cited by 162 · see citing works

Statin therapy for Alzheimer’s disease

Petanceska, S. S., DeRosa, S., Olm, V., Diaz, N. S., Sharma, A., Bryant‐Thomas, T., Duff, K., Pappolla, M. A., & Refolo, L. M. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0026-2 · Cited by 153 · see citing works

A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia

Katona, C., Hunter, B. N., & Bray, J. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199802)13:2 · Cited by 148 · see citing works

A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial

Mittelman, M. S. (1996) · JAMA · doi:10.1001/jama.276.21.1725 · Cited by 139 · see citing works

Neuropsychological Patterns and Language Deficits in 20 Consecutive Cases of Autopsy-Confirmed Alzheimer's Disease

Price, B. H., Gurvit, H. I., Weıntraub, S., Geula, C., Leimkuhler, E., & Mesulam, M. M. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540090038008 · Cited by 136 · see citing works

Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients.

Pappas, B., Bayley, P., Bui, B. K., Hansen, L., & Thal, L. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00090-7 · Cited by 122 · see citing works

A Double-Blind Comparison of Trazodone and Haloperidol for Treatment of Agitation in Patients With Dementia

Sultzer, D. L., Gray, K. F., Günay, İ., et al. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199705010-00008 · Cited by 122 · see citing works

Conditions associated with Alzheimer's disease at death

Chandra, V., Bharucha, N. E., & Schoenberg, B. S. (1986) · Neurology · doi:10.1212/wnl.36.2.209 · Cited by 116 · see citing works

On Drawing Impairment in Alzheimer's Disease

Kirk, A., & KERTESZ, A. E. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530130083024 · Cited by 115 · see citing works

Early Alzheimer's Disease

Kawas, C. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp022295 · Cited by 114 · see citing works

Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias

Jorm, A. F. (1991) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189530 · Cited by 110 · see citing works

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

Watkins, P. B. (1994) · JAMA · doi:10.1001/jama.271.13.992 · Cited by 110 · see citing works

Clock Drawing Test in Very Mild Alzheimer's Disease

Esteban-Santillan, C., Praditsuwan, R., Veda, H., et al. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb04543.x · Cited by 108 · see citing works

The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease

Doraiswamy, P. M., Kaiser, L., Bieber, F., & Garman, R. L. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200110000-00003 · Cited by 104 · see citing works

Combination Therapy of Donepezil and Vitamin E in Alzheimer Disease

Klatte, E. T., Scharre, D. W., Nagaraja, H. N., Davis, R. A., & Beversdorf, D. Q. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200304000-00010 · Cited by 81 · see citing works

An Open Trial of Valproate for Agitation in Geriatric Neuropsychiatric Disorders

Porsteinsson, A. P., Tariot, P. N., Erb, R., & Gaile, S. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00010 · Cited by 70 · see citing works

Human apolipoprotein E4 accelerates β‐amyloid deposition in APPsw transgenic mouse brain

Carter, D. B., Dunn, E., McKinley, D. D., Stratman, N. C., Boyle, T. P., Kuiper, S. L., Oostveen, J. A., Weaver, R. J., Boller, J. A., & Gurney, M. E. (2001) · Annals of Neurology · doi:10.1002/ana.1134 · Cited by 68 · see citing works

Development of a new treatment for alzheimer’s disease and parkinson’s disease using anti-aggregatory β-synuclein-derived peptides

Windisch, M., Hutter‐Paier, B., Rockenstein, E. M., Hashimoto, M., Mallory, M. E., & Masliah, E. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0012-8 · Cited by 49 · see citing works

Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study

Zandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47 · see citing works

Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study

Ross, G. W. (1997) · JAMA · doi:10.1001/jama.277.10.800 · Cited by 30 · see citing works

Health Economical Aspects of Alzheimer Disease and its Treatment

Wimo, A., & Winblad, B. G. (2001) · Psychogeriatrics · doi:10.1111/j.1479-8301.2001.tb00047.x · Cited by 21 · see citing works

Complementary and Alternative Medicines for Alzheimer's Disease

Ott, B. R., & Owens, N. J. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901100401 · Cited by 21 · see citing works

Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5 · see citing works

Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · see citing works

Revising the definition of Alzheimer's disease: a new lexicon

Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · see citing works

Alzheimer Mechanisms and Therapeutic Strategies

Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works

Mediterranean diet and risk for Alzheimer's disease

Scarmeas, N., Stern, Y., Tang, M., Mayeux, R., & Luchsinger, J. A. (2006) · Annals of Neurology · doi:10.1002/ana.20854 · Cited by 1,103 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease

Deane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58642 · Cited by 619 · see citing works

The Alzheimer’s Disease Clinical Spectrum

Atri, A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.009 · Cited by 623 · see citing works

Increased App expression in a mouse model of Down’s syndrome disrupts NGF transport and causes cholinergic neuron degeneration

Salehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543 · see citing works

Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project

Kuriyama, S., Hozawa, A., Ohmori, K., Shimazu, T., Matsui, T., Ebihara, S., Awata, S., Nagatomi, R., Arai, H., & Tsuji, I. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.355 · Cited by 428 · see citing works

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363 · see citing works

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

Gold, M., Alderton, C., Zvartau-Hind, M., Egginton, S., Saunders, A. M., Irizarry, M., Craft, S., Landreth, G., Linnamägi, Ü., & Sawchak, S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318845 · Cited by 361 · see citing works

Evolution of the Aging Brain Transcriptome and Synaptic Regulation

Loerch, P. M., Lu, T., Dakin, K. A., Vann, J. M., Isaacs, A., Geula, C., Wang, J., Pan, Y., Gabuzda, D. H., Li, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003329 · Cited by 334 · see citing works

Oxidative stress mediates tau-induced neurodegeneration in Drosophila

Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318 · see citing works

Parietal cortex matters in Alzheimer's disease: An overview of structural, functional and metabolic findings

Jacobs, H. I. L., Van Boxtel, M. P. J., Jolles, J., Verhey, F. R. J., & Uylings, H. B. M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.06.009 · Cited by 293 · see citing works

Changing perspectives regarding late-life dementia

Fotuhi, M., Hachinski, V., & Whitehouse, P. J. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.175 · Cited by 291 · see citing works

Neurophysiology of sleep and wakefulness: basic science and clinical implications

Schwartz, J., & Roth, T. (2008) · Current Neuropharmacology · doi:10.2174/157015908787386050 · Cited by 289 · see citing works

Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease

Reed, B. R., Mungas, D. M., Kramer, J. H., Ellis, W., Vinters, H. V., Zarow, C., Jagust, W. J., & Chui, H. C. (2007) · Brain · doi:10.1093/brain/awl385 · Cited by 282 · see citing works

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial

Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., & Bagiella, E. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150493 · Cited by 285 · see citing works

Memantine: A Review of Its Use in Alzheimer’s Disease

Robinson, D. M., & Keating, G. M. (2006) · Drugs · doi:10.2165/00003495-200666110-00015 · Cited by 277 · see citing works

Epigenetic regulation in the pathophysiology of Alzheimer's disease

Chouliaras, L., Rutten, B. P. F., Kenis, G., Peerbooms, O., Visser, P. J., Verhey, F., van Os, J., Steinbusch, H. W. M., & van den Hove, D. L. A. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.002 · Cited by 262 · see citing works

The association between Mediterranean diet adherence and Parkinson's disease

Alcalay, R. N., Gu, Y., Mejia‐Santana, H., Cote, L., Marder, K. S., & Scarmeas, N. (2012) · Movement Disorders · doi:10.1002/mds.24918 · Cited by 228 · see citing works

Long-term course and effectiveness of combination therapy in Alzheimer disease

Atri, A., Shaughnessy, L. W., Locascio, J. J., & Growdon, J. H. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31816653bc · Cited by 230 · see citing works

Global CNS Transduction of Adult Mice by Intravenously Delivered rAAVrh.8 and rAAVrh.10 and Nonhuman Primates by rAAVrh.10

Yang, B., Li, S., Wang, H., Guo, Y., Gessler, D. J., Cao, C., Su, Q., Kramer, J., Zhong, L., Ahmed, S. S., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.68 · Cited by 213 · see citing works

Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review

Hutchinson, A. D., & Mathias, J. L. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100669 · Cited by 187 · see citing works

Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease

Luchsinger, J. A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.048 · Cited by 171 · see citing works

Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease

Kulijewicz‐Nawrot, M., Verkhratsky, A., Chvátal, A., Syková, E., & Rodríguez, J. J. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2012.01536.x · Cited by 160 · see citing works

Assessment of endothelial function in Alzheimer’s disease: Is Alzheimer’s disease a vascular disease?

Dede, D. S., Yavuz, B., Yavuz, B. B., Cankurtaran, M., Halil, M., Ulger, Z., Cankurtaran, E. S., Aytemir, K., Kabakci, G., & Ariogul, S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01378.x · Cited by 142 · see citing works

Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis’ still alive?

Tayeb, H. O., Murray, E. D., Price, B. H., & Tarazi, F. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.789856 · Cited by 119 · see citing works

Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment

Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108 · see citing works

The staging and assessment of moderate to severe Alzheimer disease

Feldman, H. H., & Woodward, M. (2005) · Neurology · doi:10.1212/wnl.65.6_suppl_3.s10 · Cited by 105 · see citing works

Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction

Pandey, A., Bani, S., Dutt, P., Kumar Satti, N., Avtar Suri, K., & Nabi Qazi, G. (2018) · Cytokine · doi:10.1016/j.cyto.2017.10.019 · Cited by 104 · see citing works

Serum albumin and beta-amyloid deposition in the human brain

Kim, J. W., Byun, M. S., Lee, J. H., Yi, D., Jeon, S. Y., Sohn, B. K., Lee, J.-Y., Shin, S. A., Kim, Y. K., Kang, K. M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010005 · Cited by 87 · see citing works

DNA Double-Strand Break Accumulation in Alzheimer’s Disease: Evidence from Experimental Models and Postmortem Human Brains

Thadathil, N., Delotterie, D. F., Xiao, J., Hori, R., McDonald, M. P., & Khan, M. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02109-8 · Cited by 94 · see citing works

Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis

Zhang, C., Griciuc, A., Hudry, E., Wan, Y., Quinti, L., Ward, J., Forte, A. M., Shen, X., Ran, C., Elmaleh, D. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19641-2 · Cited by 99 · see citing works

Towards Retinoid Therapy for Alzheimers Disease

Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486581 · Cited by 91 · see citing works

Functional craniology and brain evolution: from paleontology to biomedicine

Bruner, E., de la Cuétara, J. M., Masters, M., Amano, H., & Ogihara, N. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00019 · Cited by 87 · see citing works

Sensitive imaging and effective capture of Cu2+: Towards highly efficient theranostics of Alzheimer's disease

Cui, Z., Bu, W., Fan, W., Zhang, J., Ni, D., Liu, Y., Wang, J., Liu, J., Yao, Z., & Shi, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.056 · Cited by 83 · see citing works

Anxiety as a Risk Factor for Cognitive Decline: A 12-Year Follow-Up Cohort Study

Gulpers, B. J. A., Oude Voshaar, R. C., van Boxtel, M. P. J., Verhey, F. R. J., & Köhler, S. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.09.006 · Cited by 68 · see citing works

Magnesium Status in Alzheimer’s Disease: A Systematic Review

Veronese, N., Zurlo, A., Solmi, M., Luchini, C., Trevisan, C., Bano, G., Manzato, E., Sergi, G., & Rylander, R. (2016) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317515602674 · Cited by 64 · see citing works

Amyloid-β: A double agent in Alzheimer's disease?

Yu, H., & Wu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111575 · Cited by 62 · see citing works

Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis

Zhao, Y., Sun, Y., Ji, H.-F., & Shen, L. (2013) · Nutrition · doi:10.1016/j.nut.2012.11.018 · Cited by 61 · see citing works

Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics

Caltagirone, C., Bianchetti, A., Luca, M. D., Mecocci, P., Padovani, A., Pirfo, E., Scapicchio, P., Senin, U., Trabucchi, M., & Musicco, M. (2005) · Drugs & Aging · doi:10.2165/00002512-200522001-00002 · Cited by 55 · see citing works

Effects of ApoE4 and maternal history of dementia on hippocampal atrophy

Andrawis, J. P., Hwang, K. S., Green, A. E., Kotlerman, J., Elashoff, D., Morra, J. H., Cummings, J. L., Toga, A. W., Thompson, P. M., & Apostolova, L. G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.020 · Cited by 54 · see citing works

Ligand-functionalized nanoliposomes for targeted delivery of galantamine

Mufamadi, M. S., Choonara, Y. E., Kumar, P., Modi, G., Naidoo, D., van Vuuren, S., Ndesendo, V. M. K., Toit, L. C. D., Iyuke, S. E., & Pillay, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.037 · Cited by 51 · see citing works

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease

Jaszberenyi, M., Rick, F. G., Szalontay, L., Block, N. L., Zarandi, M., Cai, R.-Z., & Schally, A. V. (2012) · Aging · doi:10.18632/aging.100504 · Cited by 48 · see citing works

Memory Enhancing Activity of Abana®: An Indian Ayurvedic Poly-Herbal Formulation

Parle, M., & Vasudevan, M. (2007) · Journal of Health Science · doi:10.1248/jhs.53.43 · Cited by 31 · see citing works

Identifying and Avoiding Confusion in Dialogue with People with Alzheimer's Disease

Chinaei, H., Currie, L. C., Danks, A., Lin, H., Mehta, T., & Rudzicz, F. (2017) · Computational Linguistics · doi:10.1162/coli_a_00290 · Cited by 30 · see citing works

Intermittent Fasting: A Promising Approach for Preventing Vascular Dementia

Yoon, G., & Song, J. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.1.1 · Cited by 20 · see citing works

Risk Factors for Colorectal Cancer

Y Peterson, C. (2015) · MOJ Surgery · doi:10.15406/mojs.2015.02.00015 · Cited by 6 · see citing works

The Relationship Between the Continuum of Elevated Adiposity, Hyperinsulinemia, and Type 2 Diabetes and Late-onset Alzheimer’s Disease: An Epidemiological Perspective

Luchsinger, J. A. (2010) · Research and Perspectives in Alzheimer's Disease · doi:10.1007/978-3-642-04300-0_7 · Cited by 3 · see citing works

Drug therapy of dementia in elderly patients. A review

Olsen, C. E., Poulsen, H. D., & Lublin, H. (2005) · Nordic Journal of Psychiatry · doi:10.1080/08039480510022936 · Cited by 18 · see citing works

Pharmacological Therapies in Alzheimer's Disease

Steinberg, M., & Lyketsos, C. G. (2010) · doi:10.1002/9780470669600.ch52 · Cited by 4 · see citing works

Drugs licensed for treating patients with alzheimer’s disease

(2012) · Nursing Older People · doi:10.7748/nop.24.6.11.s10

Cholinesterase Inhibitors in the Clinical Management of Alzheimer's Disease: Importance of Early and Persistent Treatment

Seltzer, B. (2006) · Journal of International Medical Research · doi:10.1177/147323000603400401 · Cited by 54 · see citing works

Effective Pharmacologic Management of Alzheimer’s Disease

Farlow, M. R., & Cummings, J. L. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.036 · Cited by 225 · see citing works